Adaptiiv said that the University of Hong Kong will begin using the company’s 3D bolus software and that it will partner with the university’s clinical oncology department to develop new applications.
Adaptiiv (Halifax, Nova Scotia) designed its software to convert cancer patient CT scan data into a digital model that can be used to print a bolus that conforms to patient anatomy, according to the company. The structure is then exported as an STL file that can be printed in a matter of hours on a healthcare facility’s existing 3D printer or on a printer provided by the company.
The software provides for uniform thickness boluses, modulated boluses for modulated electron radiation therapy (MERT), high-dose-rate (HDR) surface brachytherapy and other potential ancillary devices. The boluses are printed using durable, tissue-equivalent materials that hold their shape and do not degrade during treatments, according to the company.
Adaptiiv is the first company in the world to receive FDA 510k clearance for 3D printing software used in radiation oncology. Founded in 1911, The University of Hong Kong is the territory’s oldest institute of higher learning and also an internationally recognized, research-led, comprehensive university.
“Bringing on the University of Hong Kong as both a client and a research partner extends Adaptiiv’s global footprint into our seventh country,” said Adaptiiv CEO Peter Hickey in a statement.
The company’s software is already used in the United States, Canada, Australia, Israel, Ireland, and England.
